The Global Oncology Partnering 2012-2018: Deal trends, players and financials report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies. LONDON , Fev. ...
Potential Companion Diagnostic Compliments MAN-01 Pipeline Glaucoma Drug NEW YORK , February 8, 2018 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), is pleased to announce an exclusive option agreement with Washington University in St. ...
New indication for ZYTIGA® in combination with prednisone provides treatment option for patients with metastatic high-risk castration-sensitive prostate cancer HORSHAM, Pa. , Feb. 8, 2018 /PRNewswire/ -- The Janssen Pharmaceutical ...
Mario Cantone, Nigel Barker, Buster Skrine, Michael Kors, Joseph Abboud, John Varvatos and others participated in national awareness campaign NEW YORK , Feb. 8, 2018 /PRNewswire/ -- The second annual Blue Jacket Fashion Show was held ...
The value of the melanoma market was estimated to be $3.3bn across the seven major markets (7MM*) in 2016. This is expected to grow to $5.5bn in 2026, at a Compound Annual Growth Rate (CAGR) of 5.3%, according to GlobalData, a leading data and ...
Milliman Report Fills Information Gap by Examining Survival Across Multiple Types of Cancer Treatment Facilities WASHINGTON , Feb. 7, 2018 /PRNewswire/ -- Patients treated with some of the most common types of cancer with chemotherapy at ...
PHILADELPHIA and SALT LAKE CITY , February 7, 2018 /PRNewswire/ -- Via Oncology, recently acquired by Elsevier, including expert-defined clinical algorithms and specific recommendations for all significant aspects of cancer care ...
Partnership Provides Patients and Caregivers Fighting Cancer Access to Life-Saving Information, Including Forums with Doctors and Fellow Patients and Personalized Alerts on New Clinical Trials TORONTO , February 6, 2018 /PRNewswire/ -- ...
The Cancer Research Society contributes 1.5 million dollars to the Oncopole to help finance exceptional research projects with the potential to make a difference in the prevention, diagnostic, and treatment of this disease MONTREAL , Feb. ...
- Phase 1 study to examine safety and tolerability of U3-1402, a potential first-in-class HER3-targeting antibody drug conjugate (ADC), in patients with metastatic EGFR-mutated NSCLC TOKYO, BASKING RIDGE, N.J., and MUNICH , Feb. 6, 2018 ...
In 2016, The Jackson Laboratory (JAX), a leading cancer research center, initiated the Maine Cancer Genomics Initiative (MCGI) to extend advanced cancer care to rural Maine patients. Through widespread access to genome tumor testing and targeted ...
Radiation therapy for prostate cancer often induces notable side effects among men, including fatigue , sleep disturbances, and feelings of anxiety and depression . However, incorporating mindfulness audio recordings into their treatment regimen has ...
A trial of the world's premier "personalized" mRNA vaccine targeting melanoma, the deadliest form of skin cancer , has commenced in the UK, marking a significant stride in oncological research and treatment ( ). Steve Young, a ...
Mice fed a vitamin D-rich diet displayed enhanced immune resistance against experimentally transplanted cancers and showed improved responses to immunotherapy. Similar outcomes were observed when a protein binding vitamin D in the blood, thus ...
The research has revealed the considerable potential of tai chi as a non-pharmacological approach to improve survival rates in advanced lung cancer patients. It underscores the importance of incorporating ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers